Have a personal or library account? Click to login
Clinical characteristics and endoscopic findings in autoimmune gastritis – A retrospective study Cover

Clinical characteristics and endoscopic findings in autoimmune gastritis – A retrospective study

Open Access
|Mar 2023

References

  1. Strickland RG, Mackar IR. A reappraisal of the nature and significance of chronic atrophic gastritis. Am J Dig Dis. 1973;18(5):426-440.
  2. Stockbrugger RW, Menon GG, Beilby JO, Mason RR, Cotton PB. Gastroscopic screening in 80 patients with pernicious anemia. Gut. 1983;24:1141-1147.
  3. Hsing AW, Hansson LE, McLaughlin JK, et al. Pernicious anemia and subsequent cancer. A Population-Based Cohort Study. Cancer. 1983;71(3):745-750.
  4. Kokkola A, Sjöblom SM, Haapiainen R, Sipponen P, Puolakkainen P, Järvinen H. The risk of gastric carcinoma and carcinoid tumours in patients with pernicious anaemia. A prospective follow-up study. Scand J Gastroenterol. 1998;33(1):88-92.
  5. Park JY, Cornish TC, Lam-Himlin D, Shi C, Monotgomery E. Gastric lesions in patients with Autoimmune Metaplastic Atrophic Gastritis (AMAG) in a tertiary care setting. Am J Surg Pathol. 2010;34(11):1591-1598.
  6. Vannella L, Lahner E, Osborn J, Annibale B. Systematic review: Gastric cancer incidence in pernicious anaemia. Aliment Pharmacol Ther. 2013;37:375-382.
  7. Sato Y, Imamura H, Kaizaki Y, et al. Management and clinical outcomes of type I gastric carcinoid patients: Retrospective, multicenter study in Japan. Dig Endosc. 2014;26(3):377-384.
  8. Yoshida K, Yamatsuji T, Matsubara M. Four cases of gastric cancer in patients with autoimmune gastritis. Kawasaki Med J. 2019;45:75-81.
  9. Whittingham S, Youngchaiyud U, Mackay IR, Buckley JD, Morris PJ. Thyrogastric autoimmune disease. Studies on the cell-mediated immune system and histocompatibility antigens. Clin Exp Immunol. 1975;19(2):289-299.
  10. Kahaly GJ, Hansen MP. Type 1 diabetes associated autoimmunity. Autoimmun Rev. 2016;15(7):644-648.
  11. Lahner E, Capasso M, Carabotti M, Annibale B. Incidence of cancer (other than gastric cancer) in pernicious anaemia: A systematic review with meta- analysis. Dig Liver Dis. 2018;50(8):780-786.
  12. Oshima T, Okugawa T, Hori K. Successful endoscopic submucosal dissection of gastric carcinoid in a patient with autoimmune gastritis and systemic lupus erythematosus. Intern Med. 2012;51(10):1211-1213.
  13. Kotera T, Itani K, Uchiyama H, et al. A rare combination of gastric mucosa-associated lymphoid tissue lymphoma, autoimmune gastritis, thyroiditis, hemolysis, and systemic lupus erythematosus. Intern Med. 2020;59(1):61-65.
  14. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–1181.
  15. Lahner E, Norman GL, Severi C, et al. Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency. Am J Gastroenterol. 2009;104:2071–2079.
  16. Annibale B, Marignani M, Azzoni C, et al. Atrophic body gastritis: distinct features associated with Helicobacter pylori infection. Helicobacter. 1997;2:57–64.
  17. Adamiec C, Folwarski M, Dubowik M, Adrych K, Kaźmierczak-Siedlecka K, Makarewicz W. Kudo’s pit pattern classification for in vivo optical diagnosis and discrimination of advanced colorectal polyps. Eur Rev Med Pharmacol Sci. 2022;26(8):2832-2839.
  18. Toh BH. Diagnosis and Classification of autoimmune gastritis. Autoimmun Rev. 2014;13: 459-462.
  19. Kulnigg-Dabsch S. Autoimmune gastritis. Wien Med Wochenschr. 2016;166:424-430.
  20. Irvine WJ, Cullen DR, Mawhinney H. Natural history of autoimmune achlorhydric atrophic gastritis. A 1-15-year follow-up study. Lancet. 1974;2:482-485.
  21. Toh BH, van Driel IR, Gleeson PA. Pernicious anemia. N Engl J Med. 1997; 337:1441-1448.
  22. Imamura H. Diagnosis of autoimmune (type A) gastritis. Gatroenterol Endosc. 2018;60: 1444-1449.
  23. Carmel R, Johnson CS. Racial patterns in pernicious anemia. Early age at onset and increased frequency of intrinsic-factor antibody in black women. N. Engl. J. Med. 1978;298:647–650.
  24. Zhang H, Jin Z, Cui R, Ding S, Huang Y, Zhou L. Autoimmune metaplastic atrophic gastritis in Chinese: a study of 320 patients at a large tertiary medical center. Scand. J.Gastroenterol. 2017;52:50-56.
  25. Purdy JK, Appelman HD, McKenna BJ. Histologic autoimmune gastritis is frequently unrecognized and twice as common as the clinical prevalence of the disease. Am J Clin Pathol. 2009;132:621–640.
  26. Hershko C, Ronson A, Souroujon M, Maschler I, Heyd J, Patz J. Variable hematologic presentation of autoimmune gastritis: age-related progression from iron deficiency to cobalamin depletion. Blood. 2006;107:1673–1679.
  27. Villanacci V, Casella G, Lanzarotto F, et al. Autoimmune gastritis: relationships with anemia and Helicobacter pylori status. Scand. J. Gastroenterol. 2017;52:674–677.
  28. Lahner E, Centanni M, Agnello G et al. Occurrence and risk factors for autoimmune thyroid disease in patients with atrophic body gastritis. Am. J. Med. 2008;121:136–141.
  29. Kalkan Ç, Soykan I. Polyautoimmunity in autoimmune gastritis. Eur.J.Intern. Med. 2016;31:79–83.
  30. Shah SC, Piazuelo MB, Kuipers EJ, Li D. AGA clinical practice update on the diagnosis and management of atrophic gastritis: Expert review. Gastroenterology2021;161:1325–1332.
  31. Annibale B, Negrini R, Caruana P, et al. Two-thirds of atrophic body gastritis patients have evidence of Helicobacter pylori infection. Helicobacter. 2001;6:225–233.
  32. Annibale B, Lahner E, Negrini R, et al. Lack of specific association between gastric autoim- munity hallmarks and clinical presentations of atrophic body gastritis. World J Gastroenterol. 2005;11:5351–5357.
  33. Mini R, Annibale B, Lahner E, Bernardini G, Figura N, Santucci A. Western blotting of totallysate of Helicobacter pylori in cases of atrophic body gastritis. Clin Chem. 2006;52:220–226.
  34. Terao S, Suzuki S, Yaita H, et al. Multicenter study of autoimmune gastritis in Japan: clinical and endoscopic characteristics. Dig Endosc. 2020;32(3):364–372.
  35. Arai J, Niikura R, Hayakawa Y, et al. Clinicopathological features of gastric cancer with autoimmune gastritis. Biomedicines. 2022;10(4):884.
  36. Boyce M, Thomsen L. Gastric neuroendocrine tumors: prevalence in Europe, USA, and Japan, and rationale for treatment with a gastrin/CCK2 receptor antagonist. Scand J Gastroenterol. 2015;50(5):550-559.
  37. Hu H, Li R, Shao L, Zhang Q, Xu R, Zhang S. Gastric lesions in patients with autoimmune metaplastic atrophic gastritis: a retrospective study in a single center. Scand J Gastroenterol. 2022;57(11):1296-1303.
DOI: https://doi.org/10.2478/amma-2023-0012 | Journal eISSN: 2668-7763 | Journal ISSN: 2668-7755
Language: English
Page range: 61 - 67
Submitted on: Jan 26, 2022
Accepted on: Mar 2, 2023
Published on: Mar 29, 2023
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2023 Gabriella Gabos, Valentin Nădășan, Iris Nădășan, Mădălina Petruț, Ioana Bernatchi, Mădălin Bălășescu, Carmen Nicolau, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.